about
Implications of NQO1 in cancer therapyA perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomicsUpdate of the NAD(P)H:quinone oxidoreductase (NQO) gene familyUDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib.Balkan endemic nephropathy: an update on its aetiologyTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesNAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotectorRegulation of Nrf2-an updateGenomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplificationUp-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injuryEffects of acupuncture at Taixi acupoint (KI3) on kidney proteome.A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors.Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion.A mechanistic and structural analysis of the inhibition of the 90-kDa heat shock protein by the benzoquinone and hydroquinone ansamycins.Quinone-induced protein handling changes: implications for major protein handling systems in quinone-mediated toxicityDevelopment of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.High-throughput screen of natural product libraries for hsp90 inhibitors.Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.Flavodoxin-Like Proteins Protect Candida albicans from Oxidative Stress and Promote Virulence.Camel milk modulates the expression of aryl hydrocarbon receptor-regulated genes, Cyp1a1, Nqo1, and Gsta1, in murine hepatoma Hepa 1c1c7 cells.Mitochondrial genome-knockout cells demonstrate a dual mechanism of action for the electron transport complex I inhibitor mycothiazole.Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups.Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxEmerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.Redox-triggered contents release from liposomes.Nrf2: a potential target for new therapeutics in liver disease.Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.Loss of NADPH quinone oxidoreductase in the prostate and enhanced serum levels of cytokine-induced neutrophil chemoattractant 2alpha in hormone-stimulated noble rats: potential role in prostatic intraepithelial neoplasia developmentNAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivativesActivation of NQO1 in NQO1*2 polymorphic human leukemic HL-60 cells by diet-derived sulforaphaneCharacterization of the threshold for NAD(P)H:quinone oxidoreductase activity in intact sulforaphane-treated pulmonary arterial endothelial cells.Release rates of liposomal contents are controlled by kosmotropes and chaotropes.Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival.Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver.Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases.NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions.Nuclear receptors in the cross-talk of drug metabolism and inflammation.
P2860
Q26783702-51005C64-E30F-423C-A6F1-3AE14CF350A4Q26852571-9E80AC15-4742-4D2F-8AC3-BE6FB0EA53DDQ27497568-5B6A6E9D-B246-48C3-A3AC-A9CAA9DA2E43Q27853065-3AB8CCF8-A402-46FD-8755-6782CFD28E6AQ28079308-D403E6C5-0C92-4D6D-912B-9D79D332F516Q28085631-12F26B06-EF1D-416B-A9F2-14C645FCBAB6Q28278566-FB4D8DD0-F16C-49DA-A798-66CB448E4A7BQ28388589-3E6D45E0-9D95-4BC5-8634-70DC412A0393Q33836661-1823CFD0-9625-46D2-91F8-CFD1F68F0016Q33866612-6006C07C-AF76-41BA-A002-8D81EDE2817CQ33948223-F2546DA8-E1E1-4284-A7BC-3E8ED424F1ECQ34137818-4222054F-8754-44ED-8E9E-E131EB347C8EQ34146957-91A1B125-E675-49B2-AF94-C781CBF6433DQ34651985-1F1EA8CF-4061-4749-9047-8790441F8D03Q34865693-40CBC159-29D0-4F88-B7EA-6AB2DF9DBA3AQ35032377-6A092FAA-64F1-4186-A4C7-D66A2F4A801FQ35127277-EE1B6758-62BF-40AD-93EC-3E1AEDA73E6AQ35169647-0DC280D1-14C8-4038-B334-BB0AAA452890Q35565444-C6AEC987-FE71-4FA1-849F-6F302A7AE729Q35760827-36A6C207-9BF8-4FF8-8D78-6CD3A2713FD6Q35937168-7A440BFD-BA85-4489-894D-CFF5D82DEE08Q36006517-B3E3AFE3-67BD-4664-A844-792266463FE3Q36474839-3B86AF11-CC97-43B7-8E7A-787DFAFF9141Q36662810-175BF96F-D268-4A07-BF6E-48F5FA1B00A4Q36846919-2CAC8EB9-36C9-4E31-9D9F-3FE5B2D5653BQ36876799-93AAEDE9-978B-480A-8E4F-7D61CAAAF002Q36990677-58B8D198-40FD-414B-A03D-74FEF9C0C1ADQ36991534-EA2AC656-8CF7-40D0-ADCC-EFD37D37081FQ37080932-673B2DE6-28D8-4F3E-B095-CEDC9130EC62Q37089301-159D7006-8F00-4802-B71A-5CB567481DFAQ37162089-E86A4B98-09E7-4069-AD4E-17AAC47B8FCCQ37170555-FBD8E774-46B5-4B1A-BF00-0D2025212B78Q37251275-FFD8458E-AA5B-406F-850D-043B79E8269FQ37364065-FD12AD49-2D73-438B-9900-E8079742E230Q37599543-A543767B-1BAB-4951-9CF2-A9AF9ABD4557Q37676777-D337291A-7C09-4478-94C5-A6BFE6041974Q37685403-D2C3BA6A-5911-4BDE-BF0C-B93FD9C4577BQ37785105-BED1132C-BABE-4B94-99FB-D43FB54F250BQ37912039-E6E21958-BDF0-4D36-8EAB-9B8BA2B9511AQ38074993-87028C11-9942-4A38-80A0-FF332BBF3542
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Quinone reductases multitasking in the metabolic world.
@ast
Quinone reductases multitasking in the metabolic world.
@en
type
label
Quinone reductases multitasking in the metabolic world.
@ast
Quinone reductases multitasking in the metabolic world.
@en
prefLabel
Quinone reductases multitasking in the metabolic world.
@ast
Quinone reductases multitasking in the metabolic world.
@en
P2860
P356
P1476
Quinone reductases multitasking in the metabolic world.
@en
P2093
David Ross
P2860
P304
P356
10.1081/DMR-200033465
P407
P577
2004-10-01T00:00:00Z